Editas Medicine Inc

Stock Chart, Company Information, and Scan Results

$2.61(as of Apr 1, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Editas Medicine Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$2.61
Ticker SymbolEDIT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees87
CountyUSA
Market Cap$241.7M
EBIDTA-94.1M
10-Day Moving Average2.35
P/E Ratio-1.45
20-Day Moving Average2.37
Forward P/E Ratio0.00
50-Day Moving Average2.13
Earnings per Share-1.80
200-Day Moving Average2.59
Profit Margin-22.72%
RSI62.37
Shares Outstanding97.9M
ATR0.20
52-Week High4.54
Volume2,060,811
52-Week Low0.91
Most Recent Support Level2.13
Book Value27.3M
Most Recent Resistance Level2.48
P/B Ratio8.49
Upper Keltner2.81
P/S Ratio5.72
Lower Keltner1.93
Debt-to-Equity Ratio2.81
Next Earnings DateUnknown
Cash Surplus100.4M
Next Ex-Dividend DateUnknown

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Editas Medicine Inc In Our Stock Scanner

As of Apr 02, 2026
example chart graphic
Scan Name: Discounted Stocks with Earnings GrowthScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.